The D round of cash capital increase has been completed, with NTD 1.2 billion (38 million USD) raised. In June 2024, the company issued a total of 20,000,000 shares in the cash capital increase, with an issue price of NTD 60 per share, totaling NTD1,200,000,000 in paid-in capital, which has been fully received.
06.01 2024
AP Biosciences Inc completed its Series D financing with 38 million USD raised in June 2024
AP Biosciences Inc completed its Series D financing with 38 million USD raised in June 2024
